Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.6%

4 terminated out of 252 trials

Success Rate

91.5%

+5.0% vs benchmark

Late-Stage Pipeline

11%

27 trials in Phase 3/4

Results Transparency

2%

1 of 43 completed with results

Key Signals

1 with results91% success

Data Visualizations

Phase Distribution

188Total
Not Applicable (76)
Early P 1 (1)
P 1 (13)
P 2 (71)
P 3 (25)
P 4 (2)

Trial Status

Recruiting87
Unknown60
Completed43
Not Yet Recruiting33
Active Not Recruiting15
Withdrawn8

Trial Success Rate

91.5%

Benchmark: 86.5%

Based on 43 completed trials

Clinical Trials (252)

Showing 20 of 20 trials
NCT05871307Not ApplicableRecruiting

Neoadjuvant vs. Intraoperative vs. Adjuvant Resection Cavity Radiotherapy of Brain Metastases

NCT07565532Recruiting

Establishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment

NCT06261047Completed

Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer

NCT07068711Recruiting

Nutritional Status of Head and Neck Cancer Patients

NCT07365124Not Yet Recruiting

MRinRT: Swansea University and SWWCC Collaboration Study.

NCT07058948Phase 2Recruiting

Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors

NCT07443618Recruiting

Measuring Fluid Buildup in Cancer Patients

NCT07550686Not ApplicableRecruitingPrimary

Comparison of Patient Understanding and Anxiety According to the Delivery Method of Educational Videos

NCT07255196Not ApplicableRecruiting

Virtual Vs Telephone Education in Radiotherapy

NCT06356584Phase 2Recruiting

Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

NCT07239466Phase 2Recruiting

A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer

NCT06964568Phase 3Recruiting

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

NCT06233981Phase 2Completed

Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis

NCT07527884Not ApplicableNot Yet Recruiting

The Effect of Radiotherapy After Separation Surgery for Spinal Metastases

NCT05417516Phase 3Recruiting

A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

NCT07523464Phase 1Not Yet Recruiting

Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC

NCT05515796Phase 2Completed

Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors

NCT07062055Phase 2Recruiting

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases

NCT07493928Recruiting

HPV After chemoRadioTherapy

NCT05514327Not ApplicableRecruiting

A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL

Scroll to load more

Research Network

Activity Timeline